Examines CPA-catalyzed reactions to form chiral compounds, suggesting efficient drug development pathways.
Herein, we report a chiral phosphoric acid (CPA)-catalyzed asymmetric Pictet–Spengler type annulation, which enables a rapid desymmetrization of prochiral dialdehydes. The 4,5-dihydropyrrolo[1,2- a ]quinoxaline (DHPQ) skeleton and a nonadjacent 1,3-stereocenter are simultaneously established for a new family of potential pharmaceutically active 1,4-dihydropyridine (1,4-DHP) compounds. The developed protocol affords high diastereoselectivity (up to 20:1 dr) and good enantioselectivity (up to 99% ee). In addition, the annulation is amenable to gram-scale operation, and the resulting adducts can be readily elaborated into diverse functional groups without erosion of enantioselectivity.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: